• Home Study Details

  • Home / Learn / Home Study CE / Home Study Details


Let's Get Moving - Minimizing Opioid Induced Constipation

Program Type

OnDemand

Credits

1.5 Contact Hour(s)

Release Date

Sunday, June 16, 2019

Offline Date:

Tuesday, June 16, 2020

ACPE Expiration Date

Monday, June 6, 2022

Target Audience

Nurse, Pharmacist, Pharmacy Technician

Cost

$0.00

  • Overview

    Chronic constipation, when broadly defined as fewer than three defecations weekly, affects about one in six Americans. The prevalence is higher in the elderly population, with some studies suggesting that 25% of individuals older than 65 have constipation.Although new-onset constipation, especially in elders, can be a sign of systemic pathology (e.g. malignancy), the overwhelming majority of those who suffer from this disorder have no discernible mucosal or structural cause and this disorder is most commonly referred to as functional constipation.  A significant segment of patients with this disorder have drug-induced constipation.Many drugs including anticholinergic drugs and calcium channel blockers may cause or contribute to constipation, but probably the most important cause of drug induced constipation is opioid induced constipation (OIC). The use of opioids for both acute and chronic pain has risen significantly in the past 20 years and accompanying this increase in opioid use has been an awareness of opioid induced bowel dysfunction.


    Handouts

    Slide Document:   19085H01_6pp.pdf
    Slide Document:   19085H01_2pp.pdf

    Financial Support By

    Bausch Health
  • Nurse

    Review the basic epidemiology and etiology of constipation in patients prescribed opioid analgesics.
    Outline the pharmacological options for the management of OIC (pharmacologic profiles, efficacy, side effects, & adverse events).
    Identify proactive actions pharmacists can take to screen patients and preemptively manage or minimize OIC.


    Pharmacist

    Review the basic epidemiology and etiology of constipation in patients prescribed opioid analgesics.
    Outline the pharmacological options for the management of OIC (pharmacologic profiles, efficacy, side effects, & adverse events).
    Identify proactive actions pharmacists can take to screen patients and preemptively manage or minimize OIC.


    Pharmacy Technician

    Review the basic epidemiology and etiology of constipation in patients prescribed opioid analgesics.
    Outline the pharmacological options for the management of OIC (pharmacologic profiles, efficacy, side effects, & adverse events).
    Identify proactive actions pharmacists can take to screen patients and preemptively manage or minimize OIC.

  • Activity Type

    Knowledge

    Universal Activity Number

    Nurse 0798-0000-19-085-H01-N

    Pharmacist 0798-0000-19-085-H01-P

    Pharmacy Technician 0798-0000-19-085-H01-T

    ACPE PharmCon, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

    PharmCon, Inc. is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

    In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.

  • Faculty

    Geoffrey Wall, PharmD, FCCP, BCPS
    Professor of Pharmacy Practice, Drake University, Internal Medicine Clinical Pharmacist, Iowa Methodist Medical Center




HARDWARE REQUIREMENTS
Standard Windows/Mac System
iPad or iPhone
Minimum screen resolution: 1024x768
Speakers or headphones
 


SOFTWARE REQUIREMENTS
Microsoft Edge
Internet Explorer 8.0 or higher
Google Chrome
Safari
Firefox 3.0.3 or higher


NETWORK REQUIREMENTS
Broadband Internet Connection:
T1, Hi-speed DSL or Cable
4G cellular connection
 
 

This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).

 

©2015 PharmCon, lnc. All Rights Reserved | Terms & Conditions | Privacy PolicyContinuing Education For Healthcare Professionals
Developed By: ITB, Inc.